Eli Lilly’s new oral pill, orforglipron, led to up to 8% weight loss in clinical trials, outperforming existing oral ...

Orforglipron, a once-daily pill, has outperformed oral semaglutide in a phase 3 clinical trial, showing greater efficacy in managing blood sugar levels and promoting weight loss.

A new pill could help patients lose more weight and gain better control of their blood sugar levels than current weight loss ...

The Matrix 5 finally gets a promising update 5 years after the last film in the franchise hit theaters. See what ...

Significant blood pressure, heart rate effects shown in placebo-controlled trial ...

A once-daily experimental GLP-1 pill shows greater weight loss and blood sugar control than current oral options, and could soon reshape obesity and diabetes care.

It looks like Apple isn’t the only company with new products launching soon. A new Sonos Play portable Bluetooth ...

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.

Trump’s proposed ACA plans carry sky-high deductibles; Rare disease advocates fume over the FDA’s mixed signals; Cardiovascular disease on the rise among young women.

Mrs. Stark entered the exam room with casts on both wrists and forearms. “One little slip on my front porch and I fractured ...

Speaking of the future, the risks of poor arterial health increase with age.

Choosing between the two biggest names in smartphones isn’t getting any easier. We compare the just-announced Galaxy S26 with ...